During a Case-Based Roundtable® event, Michael J. Birrer, MD, PhD, moderated a discussion on what factors affect the need for ...
PDS Biotechnology's HPV-directed immunotherapy is sparking optimism in the biotech industry. Click here to find out why I am ...
Keytruda (pembrolizumab), for two types of gynecologic cancers. The first indication involves Keytruda in combination with carboplatin and paclitaxel, followed by Keytruda as a single agent, for the ...